Share
4,691 Posts.
lightbulb Created with Sketch. 1847
clock Created with Sketch. 31/01/24
10:39
Share
Much appreciate your input Fibber.
Originally posted by Crowdoc:
↑
I attended the investor meeting in Melbourne on Mon 30 Jan. The explanation for the delay was reiterated as due to testing on the battery lead needing to take longer than expected. The lead has to be shown to continue to work despite chest movement due to respiration for the life of the battery - about 4-5 years. So a large number of movement cycles need to be simulated. They underestimated the time to get access and duration of this until informed by an expert consultant late in 2023. They did not state any other difficulties and reiterated the view that FDA approval is expected in Q1 2025.
Expand
Originally posted by McQuade:
↑
I was there also.
Expand
I'm sure all us shareholders that are unable to attend the presentations are appeeciative of the feedback, especially with the Q and A sessions and informal discourse thereafter. I was frustrated when i realised that the timing of the presentations (once again!) coincided with a previously prepared travel arrangement with my family, and thus I am following the daily news from afar.
(20min delay)